As of 4:15pm ET
| -0.16 / -4.98%|
The 3 analysts offering 12-month price forecasts for Merrimack Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 15.00 and a low estimate of 7.00. The median estimate represents a +129.51% increase from the last price of 3.05.
The current consensus among 4 polled investment analysts is to Hold stock in Merrimack Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.